-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NuwoMZA9FxELv2iJH1ugWMSS+sfv5L+jG8qnGSpfPzBz2QABX2SkvXbofQ9iyQdz XxOx3JLyVRTLWgGEH4nj2A== 0001193125-07-169473.txt : 20070802 0001193125-07-169473.hdr.sgml : 20070802 20070802162457 ACCESSION NUMBER: 0001193125-07-169473 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070802 DATE AS OF CHANGE: 20070802 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CORTEX PHARMACEUTICALS INC/DE/ CENTRAL INDEX KEY: 0000849636 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330303583 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-108948 FILM NUMBER: 071020792 BUSINESS ADDRESS: STREET 1: 15241 BARRANCA PKWY CITY: IRVINE STATE: CA ZIP: 92718 BUSINESS PHONE: 7147273157 MAIL ADDRESS: STREET 1: 15241 BARRANCA PARKWAY CITY: IRVINE STATE: CA ZIP: 92718 424B3 1 d424b3.htm PROSPECTUS SUPPLEMENT NO. 5 Prospectus Supplement No. 5

Filed Pursuant to Rule 424(b)(3)
Registration No. 333-108948

PROSPECTUS SUPPLEMENT NO. 5

(To Prospectus Dated March 2, 2004)

CORTEX PHARMACEUTICALS, INC.

5,164,366 Shares of Common Stock

($0.001 par value)

This prospectus supplement supplements information contained in that certain prospectus dated March 2, 2004 of Cortex Pharmaceuticals, Inc. (the “Company”), relating to the offer and sale from time to time of up to 1,664,968 shares of the Company’s outstanding common stock, and up to 3,499,398 shares of the Company’s common stock issuable upon exercise of warrants, which are held by certain stockholders and warrant holders named in the prospectus under the section entitled “Selling Stockholders.” This prospectus supplement is not complete without, and may not be delivered or utilized except in connection with, the prospectus, including any amendments or supplements thereto.

The following amends the “Selling Stockholders” section set forth in the prospectus:

The table setting forth the names of the selling stockholders shall be amended to change the name “Basso Equity Opportunity Holding Fund Ltd.” to “Basso Private Opportunities Holding Fund Ltd.” The entry for Basso Equity Opportunity Holding Fund Ltd. shall be amended as follows:

 

Name

    Common Stock
Owned Prior
to the Offering		    Common Stock
Being Offered
Pursuant to
this Prospectus		    Common Stock
Owned Upon
Completion of
this Offering		    Percentage of
Common Stock
Owned Upon
Completion of
this Offering

Basso Private Opportunities Holding Fund Ltd. (1)

    133,334    133,334    53,500    *
(1) The last two columns in the foregoing table consist of 53,500 shares subject to warrants that are currently exercisable and are not being offered pursuant to this prospectus. Basso Private Opportunities Holding Fund Ltd. was formerly known as Basso Equity Opportunity Holding Fund Ltd. Basso Capital Management, L.P. (“Basso”) is the Investment Manager to Basso Private Opportunities Holding Fund Ltd. Howard I. Fischer is a managing member of Basso GP, LLC, the General Partner of Basso.

 

All information in this prospectus supplement is as of August 2, 2007.

 

The date of this prospectus supplement is August 2, 2007.

-----END PRIVACY-ENHANCED MESSAGE-----